(Q33452783)
Statements
A phase I study of recombinant interleukin 2 in melanoma patients. Toxicity and clinical effects (English)
R Marolda
F Belli
A Prada
F Villani
C Gambacorti-Passerini
A Galazka
G Parmiani
1 December 1987
scientific article